EE63 Cost-Effectiveness of Olaparib Plus Bevacizumab First-Line Maintenance in Ovarian Cancer Alongside the PAOLA-1 Trial
L. Perrier, K. Zarca, T. Cadet, M. Morelle, C. Cropet, A. Burges, S.C. Cecere, I. Palacio, S. Polterauer, H. Yoshida, P. Vuylsteke, N. Colombo,T.J. Nøttrup, C. Abdeddaim, A. El-Balat, S. Cinieri,A. Herrero, M.C. Kaminski,E. Pujade-Lauraine, I. Durand-Zaleski Value in Health（2023）
AI 理解论文
溯源树
样例
